Mozer Anthony B, Pender John R, Chapman William H H, Sippey Megan E, Pories Walter J, Spaniolas Konstantinos
Department of Surgery, The Brody School of Medicine at East Carolina University, Greenville, NC, USA.
Division of Advanced Laparoscopic, Gastrointestinal and Endocrine Surgery, East Carolina University Brody School of Medicine, 600 Moye Boulevard, Greenville, NC, 27834, USA.
Obes Surg. 2015 Nov;25(11):2088-92. doi: 10.1007/s11695-015-1656-0.
Laparoscopic procedures for the treatment of morbid obesity are commonly offered to patients with comorbidities previously thought to carry prohibitive operative risk. In this study, we reviewed characteristics and perioperative outcomes of patients with dialysis-dependent renal failure (DDRF) who underwent laparoscopic bariatric procedures.
The American College of Surgeons National Surgical Quality Improvement Program (ACS-NSQIP) database from 2006 to 2011 was reviewed. Preoperative characteristics and 30-day outcome data of patients who underwent three common laparoscopic procedures were analyzed using ANOVA and Pearson chi-squared tests.
One hundred thirty-eight patients (52.5 % female) with DDRF and a median body mass index (BMI) of 45.5 kg/m(2) were identified; 33.8 % (n = 47) underwent laparoscopic banding (LAGB), 48.9 % (n = 68) laparoscopic Roux-en-Y gastric bypass (RYGB), and 16.5 % (n = 23) laparoscopic sleeve gastrectomy (LSG). No differences were found among groups in age, prevalence of American Society of Anesthesiology IV classification, BMI, weight, gender, prevalence of diabetes, and vascular or neurologic comorbidities. Total operation time and length of hospital stay were significantly different between groups. Mortality was 0.7 %, and overall morbidity was 5.8 %. The case mix reflected a decrease in LAGB procedures from 45.5 to 23.3 % from 2006-2009 to 2010-2011 and an increase in LSG procedures from 9.1 to 24.7 % (p < 0.006).
When performed in selected DDRF patients, bariatric surgery is safe. An increase in LSG with a concurrent decline in LAGB procedures was demonstrated over the period of the study.
腹腔镜手术治疗病态肥胖症通常适用于那些先前被认为手术风险过高的合并症患者。在本研究中,我们回顾了接受腹腔镜减肥手术的透析依赖型肾衰竭(DDRF)患者的特征和围手术期结果。
回顾了美国外科医师学会国家外科质量改进计划(ACS-NSQIP)2006年至2011年的数据库。使用方差分析和Pearson卡方检验分析接受三种常见腹腔镜手术患者的术前特征和30天结果数据。
确定了138例DDRF患者(52.5%为女性),中位体重指数(BMI)为45.5kg/m²;33.8%(n = 47)接受了腹腔镜束带术(LAGB),48.9%(n = 68)接受了腹腔镜Roux-en-Y胃旁路术(RYGB),16.5%(n = 23)接受了腹腔镜袖状胃切除术(LSG)。各组在年龄、美国麻醉医师协会IV级分类患病率、BMI、体重、性别、糖尿病患病率以及血管或神经合并症方面均未发现差异。各组之间的总手术时间和住院时间存在显著差异。死亡率为0.7%,总体发病率为5.8%。病例组合反映出LAGB手术从2006 - 2009年的45.5%降至2010 - 2011年的23.3%,而LSG手术从9.1%增至24.7%(p < 0.006)。
在选定的DDRF患者中进行减肥手术是安全的。在研究期间,显示出LSG手术增加而LAGB手术同时减少的情况。